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ABSTRACT
In the yeast U1 snRNP the Prp39/Prp42 heterodimer
is essential for early steps of spliceosome assem-
bly. In metazoans no Prp42 ortholog exists, rais-
ing the question how the heterodimer is function-
ally substituted. Here we present the crystal struc-
ture of murine PRPF39, which forms a homodimer.
Structure-guided point mutations disrupt dimer for-
mation and inhibit splicing, manifesting the homod-
imer as functional unit. PRPF39 expression is con-
trolled by NMD-inducing alternative splicing in mice
and human, suggesting a role in adapting splicing
efficiency to cell type specific requirements. A phy-
logenetic analysis reveals coevolution of shortened
U1 snRNA and the absence of Prp42, which cor-
relates with overall splicing complexity in different
fungi. While current models correlate the diversity
of spliceosomal proteins with splicing complexity,
our study highlights a contrary case. We find that
organisms with higher splicing complexity have sub-
stituted the Prp39/Prp42 heterodimer with a PRPF39
homodimer.
INTRODUCTION
Splicing is an essential step in precursor messenger RNA
(pre-mRNA) processing. It is catalyzed by the spliceosome,
a multi-megadalton protein RNA complex (1). This elab-
orate molecular machine consists of five core components,
the U1, U2, U4, U5 and U6 snRNPs, and multiple auxil-
iary proteins, which are assembled in a stepwise manner for
each splicing event on a pre-mRNA substrate. It is crucial
that splice site (ss) recognition is consistently accurate, as
a single mistake can result in the production of a nonfunc-
tional protein and in some cases in disease. For 5`ss recog-
nition in the early steps of splicing, the U1 snRNP plays a
critical role. During this step a single stranded region of the
U1 snRNA base pairs with the 5`ss of the pre-mRNA (2).
Structural work on the spliceosomal machinery has
mainly been conducted in the human or Saccharomyces
cerevisiae (referred to as yeast in the following) systems. The
yeast system more readily yields stable complexes for struc-
tural analysis and serves as a good model for spliceosomes
from higher eukaryotes. The human spliceosome is more
complex than the spliceosome in yeast, including around 80
additional, mostly non-snRNP, proteins (3,4), that are con-
sidered to yield increased functional versatility such as alter-
native splicing. However, the U1 snRNP seems to represent
an exception. The yeast U1 snRNA alone is already ∼3.5
times larger than its human counterpart (5,6). Purified hu-
manU1 snRNP containsmerely ten proteins (seven Smpro-
teins, hU1-70K, hU1A, and hU1C). In contrast, seven addi-
tional, stably associated proteins (yLuc7, yNam8, yPrp39,
yPrp40, yPrp42, ySnu56 and ySnu71) can be found in pu-
rified yeast U1 snRNPs. Among the yeast U1 proteins,
yPrp42 and ySnu56 have no known human orthologs (7,8).
Earlier studies in yeast showed that yPrp39 associates
with the U1 snRNP and is necessary for pre-mRNA splic-
ing (9). A cryo-electron microscopy (cryo-EM) study of the
yeast U1 snRNP (10) showed that the core components
of the U1 snRNP are connected to its auxiliary proteins
through a yPrp39/yPrp42 heterodimer. Both yPrp39 and
yPrp42 consist mainly of half-a-tetratricopeptide repeats
(HAT repeats). HAT-repeat proteins are mostly involved
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in protein-protein and protein-RNA interactions and act
as scaffolding proteins. They participate in various RNA
processing pathways, prominent examples being SART3,
which is involved in splicing and translesion DNA synthe-
sis (11) and RNA14, which is important for mRNA 3′-
end maturation (12). Furthermore, a cryo-EM structure of
a yeast pre-catalytic pre-B complex (13) revealed that the
contact between the U1 and U2 snRNP is largely medi-
ated by the yPrp42/yPrp39 heterodimer. In the pre-B com-
plex, yPrp39 contacts theU2-specific protein yLea1 (human
homolog U2A’) via its N-terminal HAT domain (HAT-
NTD), and a positively charged groove in the HAT-NTD
of yPrp42 accommodates theU2 snRNA.Moreover, a yeast
pre-spliceosome structure (14) provided novel insights into
the early spliceosome assembly steps, showing two inter-
faces between the U1 snRNP and the U2 snRNP. The more
stable interaction is mediated by yPrp39 and yLea1. These
findings indicate that the yPrp39/yPrp42 heterodimer is
crucial for the relative spatial positioning of the U1 and U2
snRNPs during early spliceosome assembly. Together, these
studies revealed a central role of the yeast yPrp39/yPrp42
heterodimer as a crucial scaffolding complex involved in
protein-protein and protein-RNA interactions at different
stages of the splicing cycle.
Notably, in human there is no Prp42 ortholog, leading to
the question how the yPrp39/yPrp42-based protein/RNA
interactions are established in the human spliceosome. Fur-
thermore, surprisingly little is known about Prp39 in higher
eukaryotes, although the protein has been demonstrated
to be essential in diverse human cell lines in independent
CRISPR-screens (15–17) indicating a similar importance
in metazoan species as in yeast. A first indication how the
loss of Prp42 may be compensated in mammals came from
a recent study. Negative stain EM data revealed the shape
of hPRPF39 to resemble the yPrp39/yPrp42 heterodimer
and co-immunoprecipitation experiments suggest that hu-
man PRPF39 (hPRPF39) forms a homodimer (10).
Murine PRPF39 (mPRPF39, 94% amino acid identity
with hPRPF39; Supplementary Figure S1) initially came to
our attention because it is alternatively spliced in murine
naı¨ve versus memory T-cells. Given the essential role of
Prp39 in spliceosome assembly and to further address the
question how the loss of Prp42 is compensated inmetazoan,
we solved the crystal structure of mPRPF39. Structural and
biophysical data reveal mPRPF39 to be arranged as a ho-
modimer that can fulfill the function of the yPrp42/yPrp39
heterodimer. Based on our structure, we investigated the ef-
fect of point mutations that interfere with dimerization and
we show that monomeric mPRPF39 reduces splicing effi-
ciency in vitro. Furthermore, a phylogenetic analysis sug-
gests a coevolutionary reduction in U1 snRNA length and
the loss Prp42 homologs. Organisms that use a PRPF39 ho-
modimer show higher splicing complexity, providing an ex-
ample for how reduced diversity of spliceosomal proteins
can increase splicing versatility.
MATERIALS AND METHODS
Cloning
Open reading frames (ORFs) encoding mPRPF39 were
amplified from a murine cDNA sample and cloned into
the pGEX-6P-1 (or pCMV-GFP-N3 or pCMV-Flag-N3)
vector using the restriction sites BamHI (XhoI) at the
5′-end and SalI (BamHI) at the 3′-end. Point mutations
were introduced according to the QuikChange protocol
(Agilent). The pGEX-6P-1 vector guides the production
of N-terminally glutathione S-transferase (GST)-tagged,
PreScission-cleavable fusion proteins. Primer sequences are
given in Supplementary Table S1. Constructs were con-
firmed by sequencing. Nucleotide sequences of all primers
used in this study are summarized in Supplementary Table
S1.
Protein expression and purification
Proteins bearing an N-terminal, PreScission-cleavable
GST-tag were produced in Escherichia coli BL21 pLys cells
in LB-medium overnight at 18◦C after induction at an
OD600 of ∼0.6 with 0.5 mM IPTG. The following steps
were performed at 4◦C. Cells were resuspended in solubi-
lization buffer (50 mM Tris/HCl, pH 8.4, 1 mM DTT) and
lysed by sonication. Cell debris was separated from the sol-
uble fraction by centrifugation for 45 min at 55 900 × g
in an Avanti J-26 XP centrifuge (Beckman Coulter). Target
proteins were captured on glutathione agarose (Macherey-
Nagel) and washed with solubilization buffer. The GST-tag
was cleaved with 1:50 PreScission on the column overnight
and for the mutant mPRPF39 variants for 4 h. The flow-
through was collected and loaded on a 1 ml Q column (GE
Healthcare). The protein was eluted with a salt gradient
from 0 mM to 500 mM followed by concentration and size
exclusion chromatography (SEC) in solubilization buffer
using a Superdex 200 column (GE Healthcare). Peak frac-
tions were analyzed by SDS-PAGE. Fractions containing
the target proteins were pooled, concentrated, and shock-
frozen in liquid nitrogen.
For production of selenomethionine-derivatized protein,
transformed E. coliRosetta2 DE3 cells were cultured in de-
fined medium containing selenomethionine (18) and at an
OD600 of ∼0.6, protein expression was induced by addi-
tion of 0.5 mM IPTG. Purification was carried out as de-
scribed above for wild type mPrp39 (mPrp39wt), except that
all buffers contained 2 mM DTT. Integrity of the purified
proteins was confirmed by MALDI-TOF mass spectrome-
try.
Crystallographic procedures
Crystals of the native protein were obtained by the sitting-
drop vapor-diffusion method at 4◦C with a reservoir solu-
tion composed of 0.1 M Bis–Tris–propane/HCl, pH 6.5,
1.8M sodium acetate. Crystals of selenomethionine-labeled
protein were obtained by the hanging-drop method at 18◦C
with a reservoir solution composed of 0.1 M Bis–Tris–
propane/HCl, pH 6.5, 1.6 M sodium acetate, 0.75 mM
TCEP. Crystals were cryo-protected with a solution com-
posed of 80%mother liquor and 20% (v/v) propylene glycol
and subsequently flash-cooled in liquid nitrogen.
Synchrotron diffraction data were collected at the beam-
lines of the MX beamlines of the BESSY II (Berlin, Ger-
many) and at beamline P14-2 of PETRA III (DESY Ham-
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(Table 1) (19). Experimental phases were determined by
the selenomethionine single-wavelength anomalous diffrac-
tion method with the AUTOSOL routine in PHENIX
(20) using PHASER (21) and SOLVE/RESOLVE (22),
using diffraction data collected from a selenomethionine-
labeled mPRPF39 crystal (Table 1). An initial, partial
model of mPRPF39 was built with the programAUTOSOL
in PHENIX (20) and completed manually by cycles of
maximum-likelihood restrained refinement using PHENIX
(23,24) including TLS refinement (25) model building with
COOT (26). Model quality was evaluated with MolPro-
bity (27) and the JCSG validation server. (28) Secondary
structure elements were assigned with DSSP (29) and
ALSCRIPT (30) was used for displaying sequence align-
ments generated by ClustalOmega (31). Structure figures
were prepared using PyMOL.
Size exclusion chromatography coupled to multi-angle light
scattering (SEC-MALS)
SEC-MALS experiments were performed at 18◦C with
buffer containing 50 mMTris/HCl, pH 8.4, 300 mMNaCl,
0.02% NaN3. 80 g of mPRPF39wt or of mPRPF39 vari-
ants were loaded onto a Superdex 200 increase 10/300 col-
umn (GE Healthcare) that was coupled to a miniDAWN
TREOS three-angle light scattering detector (Wyatt Tech-
nology) in combination with a RefractoMax520 refractive
index detector. For calculation of the molecular mass, pro-
tein concentrations were determined from the differential
refractive index with a specific refractive index increment
(dn/dc) of 0.185ml/g.Datawere analyzedwith theASTRA
6.1.4.25 software (Wyatt Technology).
Immuno-biochemical assays
For immunoprecipitations (IPs), HEK293 cells were lysed
in RIPA buffer (10 mM Tris/HCl, pH7.5, 100 mM NaCl,
2 mM EDTA, 1% (v/v) NP-40, with proteinase inhibitors).
100 mg of lysate were diluted in 400 ml RIPA buffer con-
taining 2% (w/v) BSA and pre-cleaned for 1 h using protein
A/G Sepharose (Invitrogen). Pre-cleaned lysates were incu-
bated with protein Flag-beads, rotating at 4◦C overnight.
Beads were washed four times in RIPA buffer. After the last
wash, SDS-sample buffer was added, samples were boiled
and analyzed by SDS-PAGE and Western blot.
T cells and RNA sequencing
Naı¨ve and memory CD8+ T cells were generated using the
OT-I system as described previously (32,33). RNA-Seq was
done essentially as described (34). Briefly, total RNAs were
prepared using RNA-Tri (Bio&SELL) and further purified
using the RNeasy mini kit (Qiagen) in combination with
a DNase I (Qiagen) treatment. RNA sequencing libraries
were prepared by using the TruSeq mRNA Library Prepa-
ration kit (Illumina). 125-bp paired-end reads were gener-
ated by using a HiSeq 2500 sequencer (Illumina) with V4
sequencing chemistry. Triplicate samples from naı¨ve and
memory T cells were sequenced (around 40 × 106 reads per
sample) and analyzed using a MISO-based pipeline (35).
In vitro splicing
Splicing-active nuclear extracts were prepared according to
(36), exceptHEK cells harvested at ca. 80% confluency were
used. For splicing analysis, m7G-capped RNAs were pro-
duced by in vitro transcription using linearized plasmid as
template. In vitro splicing assays were performed in 52%
HEK nuclear extract, incubating 1 fmol of pre-mRNA and
5 g of protein or equivalent volume of purification buffer
per 25-l reaction mixture under splicing conditions for 30
min. The reaction was stopped by proteinase K treatment,
followed by RNA extraction. Twenty percent of the RNA
was reverse-transcribed and analyzed by RT-PCR.
RT-PCR
RT-PCRs were done as previously described (37) Briefly,
RNA was extracted using RNATri (Bio&Sell) and 1 mg
RNA was used in a gene-specific RT-reaction. Low-cycle
PCR with a 32P-labeled forward primer was performed,
products were separated by denaturing PAGE and quanti-
fied using a Phosphoimager and ImageQuantTL software.
Bioinformatics
U1 snRNA sequences were extracted from Rfam (38) and
NCBI (39). Protein sequences of Prp39 and Prp42 or-
thologs were extracted from NCBI and the canonical iso-
form was defined using UniProt (40). RNA secondary
structure predictions were performed using the RNAstruc-
ture Web Server (41). ClustalOmega was used for multi-
ple sequence alignments (31). The common tree taxonomy
tools from NCBI was used to create a phylogenetic tree us-
ing selected species. The tree was visualized using Interac-
tive Tree Of Life (42).
RESULTS
mPRPF39 forms a homodimer
Full-length M. musculus mPRPF39 was purified, crystal-
lized and the structure was determined at 3.3 A˚. The elec-
tron density was of excellent quality that readily allowed
to trace the amino acid sequence (Supplementary Figure
S2). The asymmetric unit contains two mPRPF39 polypep-
tide chains that are practically indistinguishable, with a
root mean square deviation (rmsd) of 0.39 A˚. The protein
is purely -helical, consisting of 12 pairs of anti-parallel
-helices arranged as half-a-tetratricopeptide (HAT) re-
peats. The overall architecture of mPRPF39 can be divided
into three distinct domains/regions: AnN-terminal domain
(HAT-NTD; residues 74–251) comprised of five HAT re-
peats and a C-terminal domain (HAT-CTD; residues 348–
602) with seven HAT repeats. The HAT-NTD and -CTD
are connected by a curved, mainly -helical linker region
(residues 252–347; Figure 1A and B).
The linker region is composed of two short-helices (L1
and L2) and an unstructured region (residues 275–294),
which connects the short -helices to a long, curved he-
lix (L3). We did not observe interpretable electron density
for the 73 N-terminal as well as the 63 C-terminal residues,
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Table 1. Crystallographic data collection and model refinement statistics
Data collection SeMet Native
Wavelength [A˚] 0.9763 0.9184
Temperature [K] 100 100
Space group C2 C2
Unit cell parameters
a, b, c [A˚];  [◦] 189.2, 73.0, 206.7; 112.4 189.5, 72.8, 207.1; 112.5
Resolution range [A˚]a 50.00–3.80 (3.90–3.80) 50.00–3.30 (3.45–3.30)
Reflectionsa
Unique 49 231 (3671) 39 170 (4809)
Completeness [%] 98.1 (97.6) 98.5 (97.9)
Multiplicity 9.9 (9.9) 4.7 (4.8)
Data qualitya
Intensity [I/(I)] 11.8 (1.5) 9.4 (0.9)
Rmeas [%] 17.7 (168.3) 14.9 (260.3)
CC1/2 99.9 (83.7) 99.8 (63.7)
Wilson B value [A˚2] 120.0 102.1




Resolution range [A˚]a 50.00–3.30 (3.42–3.30)
Reflectionsa 38 901 (3770)
Rworka 0.246 (0.443)
Rfreea 0.293 (0.443)
Contents of an asymmetric unit
Residues, Atoms 1019, 8592
Mean B-factor [A˚2] 154.5
RMSD from target geometry
Bond lengths [A˚] 0.005
Bond angles [◦] 1.03
Validation statistics
Ramachandran plot
Residues in allowed regions [%] 4.6
Residues in favored regions [%] 95.7
MOLPROBITY scoreb 2.1
MOLPROBITY Clashscore b,c 16.2
aData for the highest resolution shell in parentheses.
bCalculated with MOLPROBITY (27).
cClashscore is the number of serious steric overlaps (>0.4) per 1000 atoms.
The two mPRPF39 molecules are arranged in an anti-
parallel manner, forming a homodimer (Figure 1B). Such
a homodimeric organization has been suggested before for
hPRPF39 (10). Homodimerization is mediated through the
concave surfaces of the HAT-CTDs, with the HAT-NTDs
facing away from the dimer interface. The overall archi-
tecture resembles the arrangement as observed for other
HAT-repeat proteins involved in mRNA processing, such
as SART3 (43) and CSTF77 (44). In mPRPF39, ∼1536 A˚2
of the surface area of each monomer are buried at the in-
terface of the dimer, and the PISA server (45) suggests the
presence of a stable dimer in solution.
To further investigate whether the dimer exists in solu-
tion, we performed analytical size exclusion chromatogra-
phy coupled to multi-angle light scattering (SEC-MALS)
to precisely determine the molecular mass of mPRPF39 in
solution. Our SEC-MALS experiments revealed a molec-
ular mass of 157 kDa, confirming the presence of dimeric
mPRPF39 in solution (calculated monomeric molecular
mass 78.3 kDa; Figure 1C). In addition, FLAG- and GFP-
tagged mPRPF39 were co-transfected into HEK 293 cells
and a FLAG-IP was performed. GFP-mPRPF39 was co-
precipitated in the presence of FLAG-mPRPF39 (Figure
1D). Thus, the mPRPF39 homodimer is also formed in a
cellular environment, in agreement with similar findings for
hPRPF39 (10).
The mPRPF39 homodimer can be disrupted by single point
mutations
We mapped the amino acid sequence conservation on the
surface of our mPRPF39 structure using The ConSurf
Server (46). A highly conserved surface patch is located on
the concave side of the HAT-CTD, exactly matching the
dimerization interface (Figure 2A and B), indicating that
presumably the homodimeric arrangement is conserved in
higher eukaryotes. Mapping the electrostatic potential to
the surfaces of themPRPF39 structure revealed two areas in
the concave surface of the HAT-CTD with a strongly pos-
itive and negative charge, respectively (Figure 2C). Upon
dimerization, these positive and negative patches recipro-
cally interact with each other (Figure 2D). Although ho-
modimerization is thus dominated by charged interactions,
the dimer is highly salt-resistant, as even NaCl at a concen-
tration of 900 mM did not lead to disruption of the dimer
(Supplementary Figure S3).
To test the importance of interacting residues for ho-






/nar/article-abstract/47/11/5867/5428331 by Freie U
niversitaet Berlin user on 18 July 2019
Nucleic Acids Research, 2019, Vol. 47, No. 11 5871
Figure 1. mPRP39 is a homodimer in structure and solution. (A) Schematic representation of the domain architecture of mPRPF39. The HAT-NTD
and HAT-CTD are colored in gradients from yellow to orange and teal to aqua, respectively; linker – pale green. Regions that are unstructured are
indicated as dotted lines. (B) Cartoon and combined cartoon/surface representation of the mPRPF39 homodimer in two orientations. Ellipse symbol –
non-crystallographic pseudo-twofold axis. One protomer is colored as in panel A, the other protomer is in gray. HAT repeats are numbered 1 through
12 starting at the N-terminus. In this and the following figures, orientations relative to panel A are indicated by rotation symbols. (C) Analysis of the
oligomeric state of mPRPF39 by SEC-MALS. Molecular mass (Mm) values across the elution peak (solid line; absorbance at 280 nm) are indicated by
the dashed line. Average Mm = 157 000 Da; theoretical monomeric mPRPF39wt Mm = 78335 Da. (D) Western blot of an Flag-IP of a cellular mixture
of Flag- and GFP-tagged mPRPF39. GFP-mPRPF39 can only be pulled down in the presence of Flag-mPRPF39. Asterisk indicates an unspecific band.
(Figure 2D). R458 and R464 are two highly con-
served residues in the positive interface patch, which
we individually mutated to oppositely charged residues
(mPRPF39R458D, mPRPF39R464D). Likewise, E576 and
D577 are highly conserved in the negative interface
patch, which we jointly converted to positively charged
residues (mPRPF39E576K/D577K). Y536 is the only aromatic
residue in the interface, which we exchanged for a tryp-
tophan to potentially disrupt the dimer due to steric hin-
drance (mPRPF39Y536W). The dimerization properties of
all variants were investigated by SEC-MALS and com-
pared to those of wild type (wt) mPRPF39. Dimerization
was unaffected and partially lost in the mPRPF39Y536W
and mPRPF39R458D variants, respectively (Figure 2E).
mPRPF39R464D and mPRPF39E576K/D577K clearly migrated
as monomers in SEC. These results confirm that dimeriza-
tion is based on the interactions between the conserved,
oppositely charged interface patches in the HAT-CTD
of mPRPF39 and demonstrate that exchange of a single
residue (mPRPF39R464D) can lead to complete disruption
of the dimer.
mPRPF39 homodimerization is functionally important
To test if the observed homodimerization is required for
the functionality of mPRPF39, we performed in vitro splic-
ing assays with mPRPF39wt and a monomeric version of
mPRPF39. For the functional assays the R464D exchange
was chosen, as it led to complete monomerization with the
least number of residue exchanges. A modified Adml con-
struct (Figure 2F) was used for in vitro splicing and the 2-
exon product, representing the main product, was quan-
tified. Splicing extracts treated with mPRPF39wt showed
a trend towards higher splicing efficiency (Figure 2G and
H), but the effect was not significant when compared to
the samples treated only with buffer. This suggests that
PRPF39 is not limiting in nuclear extracts, so that exoge-
nous PRPF39 does not strongly affect splicing. In contrast,
samples treated with mPRPF39R464D showed significantly
reduced splicing levels compared to both, samples treated
with only buffer or mPRPF39wt. These findings indicate
that the mPRPF39 homodimer represents the functional
unit of mPRPF39 and is required for splicing.
mPRPF39 is an NMD target
Our data indicate that reducing the level of the active
mPRPF39 homodimer can be used to control splicing effi-
ciency. Interestingly, the prpf39 gene has an alternative exon
which contains a premature stop codon (Figure 3A). The
alternative exon and its flanking regions are highly con-
served between mouse and human (Supplementary Figure
S4). Upon inclusion of the alternative exon, the premature
stop codon could potentially lead to NMD and might thus
regulate PRPF39 levels. RNA-Seq and RT-PCR validation
in independent samples of murine T-cells showed that in-
clusion of the alternative exon is strongly increased in mem-
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Figure 2. Impact of dimerization on splicing. (A) Surface representation of a mPRPF39 monomer. Interface and non-interface residues are colored teal
and grey, respectively. View identical to the lower panel of Figure 1B. (B) Sequence conservation projected onto the surface of mPRPF39. Color-coding
according to bins: bin 9 (magenta) contains themost conserved positions, bin 1 (cyan) contains themost variable positions. The homodimer interface on the
concave side of theHAT-CTD is highly conserved. (C) Electrostatic potentialmapped on the surface ofmPRPF39. The homodimer interface on the concave
side of the HAT-CTD is carpeted by complementary patches of positive and negative surface potential. (D) Zoom into the dimerization interface. Amino
acid residues subjected to site-directed mutagenesis are indicated in light blue (mPRPF39R458D), blue (mPRPF39R464D), red (mPRPF39E576K/D577K) and
black (mPRPF39Y536W). Same view as upper panel in Figure 1B. (E) Analysis of the oligomeric states of mPRPF39 variants in solution by SEC-MALS.
Molecular mass (Mm) values across the elution peaks (solid lines; absorbance at 280 nm; legend provided in the inset) are indicated by the dashed lines,
average Mm values are indicated next to the respective peaks. Theoretical monomeric mPRPF39wt Mm = 78335 Da. mPRPF39wt and mPRPF39Y536W
migrate as dimers, mPRPF39R458D forms a mixture of molecular species, mPRPF39R463D and mPRPF39E576K/D577K migrate as monomers. (F) Schematic
representation of the modified 3-exon/2-intron Adml construct used for in vitro splicing. (G) Exemplary gel of RT-PCR analysis of an in vitro splicing
reaction, comparing buffer-, mPRPF39wt- and mPRPF39R464D-treated samples. mPRPF39wt and mPRPF39R464D treatments lead to elevated splicing
and significantly reduced splicing. The asterisk indicates a non-specific band. (H) Quantification of RT-PCRs of four biologically independent in vitro
splicing experiments performed in technical triplicates. Values represent means ± standard deviations. Significance was estimated via a one-sample t-test
(*P ≤ 0.05; **P ≤ 0.01).
different murine tissue types, we observed that inclusion of
the alternative exon is particularly high in testis and low in
lymph node (Figure 3D).
Detection of the exon in the mRNA suggests that the in-
clusion mRNA isoform is not a strong NMD target. To ad-
dress whether inclusion leads to degradation at all, cells of
a murine and human T-cell line (EL4 and Jsl1, respectively)
were treated with cycloheximide (CHX). RT-PCR demon-
strated an increase in the isoform containing the alterna-
tive exon in cells treated with CHX (Figure 3E–H), con-
firming that inclusion of the alternative exon inducesNMD.
This effect was moderate, indicating that the corresponding
mRNA is only a weak NMD target. However, regardless of
whether the inclusion isoform is degraded or translated, this
isoformwill lead to reduced functional protein (Supplemen-
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Figure 3. Alternative splicing of prpf39 pre-mRNAwith resulting mRNA and protein isoforms. (A) An alternative exon (orange) can either be included or
excluded. Upon exon exclusion, the mRNA can be translated to full-length mPRPF39; upon exon inclusion, a premature stop codon is introduced, which
may lead to NMD or production of a non-functional truncated mPRPF39. Red arrows indicate location of primers used for RT-PCR. (B) Representative
validation of RNA-seq results by RT-PCR. (C) Quantification of validation as shown in panel B. Percent spliced in (PSI) values represent means± standard
deviations for four independent experiments. (D) Exemplary gel of RT-PCR in different murine tissues. The degree of alternative exon inclusion is tissue
specific, with the highest inclusion in testis and the lowest in lymph node. Results of quantification of experiments performed with samples from three
individual mice are shown below the respective lanes. Values represent means ± standard deviations. (E–H) Analysis of mprpf39 (pre-)mRNAs in mouse
EL4 cells (E, F) and human Jsl1 cells (G, H). Left – representative RT-PCR analyses; right – quantification. DMSO/CHX –DMSO/cycloheximide-treated
samples. In the CHX treated cells, an accumulation of the transcript containing the alternative exon can be seen, indicating that this isoform is an NMD-
target. Values represent means± standard deviations of three independent experiments. Significance was estimated via a one-sample T-test (*P≤0.05, **P
≤0.01).
the C-terminal domain involved in dimerization and will
thus represent a dominant negative protein isoform. Fur-
thermore, the importance of the alternative exon to regulate
PRPF39 protein levels is supported by its conservation and
the conserved effect as weak NMD exon between mouse
and human.
A PRPF39 homodimer might functionally substitute for the
yPrp39/yPrp42 heterodimer in metazoans
Although a search using the DALI server (47) iden-
tified murine CSTF-77 (PDB entry 2OOE (44)), its
Kluyveromyces lactis ortholog RNA14 (PDB entry
4EBA (12)) and human SART3 (PDB entry 5JPZ, DOI:
10.2210/pdb5JPZ/pdb) as the closest structural neighbors
of mPRPF39 (Supplementary Table S2), the structurally
most similar snRNP proteins were yPrp39 and yPrp42
(PDB entry 5UZ5 (10); rmsd of 7.6/4.5 A˚ for 583/539
number of residues, respectively). While all three proteins
share the same domain organization, mPRPF39 and
yPrp42 contain an additional -helix in their HAT-NTDs
(Supplementary Figure S7 and Supplementary Discus-
sion). Moreover, while the linker region is the structurally
most divergent part in the three proteins (Supplementary
Figures S7 and S8 and Supplementary Discussion), the
yPrp42 linker with two -helices is more similar to the
three-helix mPRPF39 linker than the yPrp39 linker that
bears only a single -helix. Thus, somewhat surprisingly,
mPRPF39 is structurally more similar to yPrp42 than
to the formal ortholog, yPrp39. Consistently, mPRPF39
exhibits a slightly higher sequence identity to yPrp42 than
to yPrp39 (23 vs. 22%, respectively). But notably in human,
hPRPF39 shows a sequence identity of 17% to yPrp42
compared to 18% to yPrp39. Hence, PRPF39 may be
considered an ortholog of both, yPrp39 and yPrp42.
Because of the similar central architecture of mPRPF39,
yPrp39 and yPrp42, also themPRPF39 homodimer is glob-
ally similar to the heterodimer of yPrp39/yPrp42 (Figure
4A). In both complexes the interaction is established via
the respective HAT-CTDs. The mPRPF39 homodimer is
more elongated than the yPrp39/yPrp42 heterodimer and
it shows less curvature in its bridging HAT-CTDs (Figure
4B and C). In contrast to the mPRPF39 homodimer inter-
face, the interface of yPrp39 and yPrp42 is dominated by hy-
drophobic interactions. Only one salt-bridge is established
between the yPrp39 CTD extension and the yPrp42 HAT-
NTD.
As (i) metazoans lack a yPrp42 ortholog, (ii) mPRPF39
shows higher sequence and structural similarity to yPrp42
than to yPrp39, (iii) mPRPF39 forms a homodimer, (iv) the
mPRPF39 homodimer resembles the yPrp39/yPrp42 het-
erodimers and (v) monomeric mPRPF39 has a detrimen-
tal effect on splicing, a PRPF39 homodimer is likely to
functionally substitute the yPrp39/yPrp42 heterodimer in
metazoan species. Consistent with this notion, the area on
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Figure 4. Comparison of mPRPF39, yPrp39 and yPrp42 structures. (A) Schematic representation of the domain architecture of mPRPF39, yPrp39 and
yPrp42. Domain coloring as in Figure 1A. Regions that are unstructured are indicated as dotted lines. (B) Ribbon diagram of the mPRPF39 homodimer
(teal and palegreen) (C) Ribbon diagram of yPrp42/yPrp39 heterodimer (dark and light gray). yPrp42 is colored in dark grey and yPrp39 in light gray.
The dimensions of the dimer are indicated in A˚. Same view as in the lower panel of Figure 1B.
the core U1 snRNP to its auxiliary proteins, is highly con-
served in mPRPF39 (Supplementary Figure S9).
PRPF39 homodimerization is evolutionarily connected to a
short U1 snRNA
The yeast U1 snRNA has a strongly elongated stem-loop
(SL) 2 compared to its human counterpart (Figure 5). It
consists of two sub-domains, the conserved SL2-1 and elon-
gated SL2-2 (Figure 5). Interestingly an evolutionary study
focusing on the SL3 (48) suggested that the duplication of
prp39 went along with an increasing length of SL3. The
recent cryo-EM structure of the yeast U1 snRNP indeed
revealed an interface between the sub-domain SL3-4 (Fig-
ure 5B) and yPrp42 (10). However, the buried surface area
between yPrp42 and SL3-4 is much smaller than between
yPrp42 and SL2-2, indicating a larger influence of SL2-2
on the evolution of the dimeric system. The convex side
of the yPrp42 HAT-NTD has a strongly positively charged
groove that accommodates SL2-2 of U1 snRNA (Figure
5A). A similar positive patch is not seen on mPRPF39 (Fig-
ure 5A), most likely because the U1 SL2 is much shorter
in metazoans than in yeast (Figure 5B) and will thus not
reach this surface area of PRPF39. This observation led us
to address the question, whether PRPF39 homodimeriza-
tion in metazoan might be evolutionarily linked to a short
U1 SL2. The sequence lengths of all annotated U1 snR-
NAs from Rfam (38) range between 96 and 825 nucleotides
(nts). Notably, higher eukaryotic U1 snRNAs all lie on the
lower end of the range, withmost of them having a length of
164 nts (Figure 6B). In contrast, fungi tend to have longer
U1 snRNA sequences, most of them over 450 nts (5). The
longer U1 snRNA likely goes hand in hand with the pres-
ence of a yeast-like SL2.However, we found a few fungi with
short U1 snRNAs; e.g., Aspergillus fumigatus and Debary-
omyces hansenii have U1 sequence lengths of 149 and 165
nts, respectively.When performing secondary structure pre-
dictions (41), we observed that their U1 snRNA structures
resemble the humanU1 structure with a short SL2 (Supple-
mentary Figure S10). TheCandida albicans snRNAwith an
intermediate length of 244 nts shows a shortened SL3, but
a yeast-like SL2.
We then queriedNCBI for hPRPF39, yPrp39 and yPrp42
orthologs. Interestingly, only fungi contain Prp42 proteins
(Figure 6A and Supplementary Figure S11). Notably, we
found that the only fungi with an annotated Prp39 but no
annotated Prp42 homolog are D. hansenii, Y. lipolytica, S.
pombe, A. fumigatus and N. crassa (Table 2, Figure 6A and
Supplementary Figure S11), which also harbor short U1
snRNAs with a metazoan-like SL2 and SL3. Thus, organ-
isms that lack Prp42, and thus most likely are dependent on
Prp39 homodimers, also contain U1 snRNAs with a short
SL2 and SL3. In contrast, the U1 snRNAs of organisms
that have both Prp39 and Prp42, and that thus most likely
use a Prp39/Prp42 heterodimer, exhibit an extended SL2
and SL3.
PRPF39 homodimerization and short U1 snRNA correlate
with higher splicing complexity
A previous analysis the exon-intron structure of genes in
fungal genomes revealed a large variation in the percentage
of intron containing genes (from 0.7 to 97) and in the num-
ber of introns per gene (2 to 18) as well as a lack of corre-
lation between splicing complexity and genome size, num-
ber of chromosomes or number of genes (49). We noticed
that fungi with less complex splicing have long U1 snRNAs
and a Prp39/42 heterodimer, while fungi with more com-
plex splicing have short U1 snRNAs and a Prp39 homod-
imer (Table 2).
Initially, D. hansenii and Y. lipolytica seemed to repre-
sent exceptions to this trend (relatively low splicing com-
plexity and short U1 snRNAs). However, BLAST searches
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Figure 5. U1 snRNA binding to yPrp42. (A) Electrostatic potential mapped on the surface of yPrp42 (left) andmPRPF39 (right) in the same orientation as
in the upper panel of Figure 1B, with the U1 snRNA SL2-2 shown as cartoon bound to yPrp42. Only yPrp42 shows the positively charged grove needed to
accommodate the RNA. Same view as in Figure 1B. (B) Schematic representations of yeast U1 snRNA (left) and of murine U1 snRNA (right). Characters
in red indicate nucleotides that are not conserved between human and murine U1 snRNA. The pale orange box highlights the elongated SL2-2 in yeast.
Table 2. Analysis of splicing complexity in connection with U1 snRNP properties. The length of SL2 and SL3 was estimated based on secondary structure
predictions of the respective U1 snRNA. The length of SL2 and SL3 of S. cerevisiae is based on the structure of U1 snRNP (10). Intron containing genes
are given in [%] and the maximal number of introns per gene is given according to Ivashchenko et al. (49)









C. glabrata x 595 147 396 1.5 2
K. lactis x 528 132 330 2.4 2
E. gossypii x 483 134 276 4.5 2
S.cerevisiae x 568 122 377 4.5 2
D. hansenii x 165 45 28 5.0 4
Y. lipolytica x 150 43 14 10.6 4
S. pombe x 149 44 22 45.6 15
A. fumigatus x 149 46 18 78.0 18
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Figure 6. Phylogenetic analysis of U1 snRNA length and presence of a hetero- or homodimer. (A) Phylogenetic tree of the organisms included in the
analysis. Phylogenetic distances are not to scale but are given in Supplementary Figure S11. Fungal clade – orange, metazoan clade – black. On the right
side, the respective median U1 snRNA lengths are plotted as a bar chart (organisms with an annotated Prp42 – black; organisms lacking an annotated
Prp42 – grey). Most fungi, except A. fumigatus and D. hansenii, have a Prp42 ortholog. A. fumigatus and D. hansenii also have short U1 snRNAs. A list of
all NCBI GeneIDs and NCBI sequence identifiers can be found in Supplementary Table S3. (B) The number of organisms plotted against the median U1
snRNA length. There are two populations that cluster around 160 nts and 550 nts.
an additional Prp39/Prp42-like protein in these species, in
addition to the annotated Prp39 ortholog. These observa-
tions suggest that D. hansenii and Y. lipolytica occupy in-
termediate phylogenetic positions, with a Prp39/Prp42 het-
erodimer, short U1 snRNAs yet only slightly elevated splic-
ing complexity (Table 2). Our observations suggest that lack
of a Prp42 ortholog, and thus a Prp39 homodimer, in con-
junction with a short U1 snRNA enabled the development
of more complex splicing patterns.
While we cannot pinpoint a particular sequence of evolu-
tionary events, these findings clearly demonstrate that pres-
ence of a Prp39/Prp42 heterodimer phylogenetically corre-
lates with U1 snRNAs bearing a long SL2 and SL3. More-
over, the shortening of theU1 SL2 and SL3 alone appears to
allow only slightly higher splicing complexity (D. hansenii,
Y. lipolytica), but it is the absence of a Prp42 homolog that
then causes dramatically increased levels of splicing com-
plexity. This indicates that relying on a Prp(f)39 homodimer
is the driving force behind diversifying splicing in these or-
ganisms.
DISCUSSION
We have determined a crystal structure of full-length
mPRPF39 composed of a HAT-NTD that is connected
via an extended linker to the HAT-CTD. This structure
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strates that mPRPF39 forms a stable homodimer in vitro
and in vivo. As disruption of the mPRPF39 homodimer has
detrimental effects on splicing, we conclude that mPRPF39
functions as a homodimer in splicing, by functionally re-
placing the Prp39/Prp42 heterodimer of the yeast system.
Given the high sequence conservation, in particular at the
dimer interface, PRPF39 most likely forms similar homod-
imers in all eukaryotes lacking a Prp42 ortholog. Prp39 and
Prp42 presumably emerged from the same ancestral gene by
gene duplication in some fungi. Our detailed structural and
phylogenetic comparisons revealed that PRP(F)39 in higher
eukaryotes should rather be considered orthologs of yeast
Prp42 than Prp39.
There are ∼80 proteins in the human spliceosome that
lack an obvious counterpart in yeast, but only few exam-
ples, such as Prp42, for which a yeast spliceosomal protein
lacks an assigned ortholog in human (3,4). We find that the
level of functional mPRPF39 has a large impact on splicing
in vitro.Furthermore, mPRPF39 expression is controlled by
alternative splicing leading to either NMD or a dominant
negative protein incapable of forming a dimer, in a tissue-
and activation-dependentmanner. These data suggest a role
of PRP(F)39 in adapting splicing efficiency to the require-
ments of specific cells or tissues. In particular in immune cell
differentiation and activation it has been shown that regu-
lated intron retention plays an important role in controlling
gene expression and function (50). Controlling PRPF39 lev-
els through inclusion of an exon containing a premature sop
codonmay contribute to fine tune splicing efficiency and in-
tron retention in such contexts, as we find it strongly regu-
lated between naive and memory T cells.
Our phylogenetic analysis show that lack of a Prp42 or-
tholog (as presently assigned) correlates with more com-
plex splicing patterns. While it is straightforward to imag-
ine mechanisms, by which splicing complexity may be in-
creased in a molecularly more complex spliceosome, the
converse scenario appears counter-intuitive. The S. cere-
visiae Prp39/Prp42 heterodimer is crucial in organizing the
spliceosome during early steps of splicing (13,14). However,
while in yeast the Prp39/Prp42 heterodimer is stably asso-
ciated with the U1 snRNP, hPRPF39 is only transiently as-
sociated with the spliceosome. A less stable association of
splicing factors with the spliceosome may allow for more
flexibility in splicing, e.g. with respect to splice site choice,
with respect to enabling other modes of alternative splic-
ing or with respect to tuning the ratio of productive and
abortive splicing, by rendering particular splicing events de-
pendent on additional factors or signals.
In the present case, increased splicing complexity corre-
lates not only with the lack of a Prp42 ortholog but also
with a U1 snRNA bearing a short SL2 and SL3. These
two features seem to allow for more flexibility in the ap-
position of U1 and U2 snRNPs during the early steps of
splicing, as PRPF39 and a short U1 SL2 and SL3 are less
tightly associated compared to yPrp42 and a long U1 SL2
and SL3. While the yPrp39/yPrp42 heterodimer mediates
a stable connection between the U1 and U2 snRNPs in
a pre-spliceosome (A-complex (14)) and the spliceosomal
pre-B complex in yeast (13), in the human spliceosome sta-
ble inter-U1/U2 snRNP contacts are lacking in the pre-B
state (51). Thus, PRPF39-mediated U1-U2 bridging in the
human system seems to depend on additional proteins and
this dependency may be one of the molecular principles, by
which splicing is additionally regulated. Other splicing fac-
tors have also been reported to be ‘reprogrammed’ from sta-
ble to facultative snRNP subunits. For example, Prp38 and
Snu23 are stable snRNP components in yeast but in human
they enter the spliceosome individually upon integration of
the tri-snRNP into the (pre-)B complex (52).
The present example provides a particularly striking ex-
ample that splicing complexity does not necessarily scale
with the number of spliceosomal protein––even though the
yPrp39/yPrp42 heterodimer in yeast represents a molecu-
larly more complex spliceosomal subunit, the molecularly
more simple PRP(F)39 homodimer in metazoan species
correlates with higher flexibility in spliceosome assembly
and thus splicing complexity. The increased splicing com-
plexity seems to be provided at least in part by a reduced
pre-organization of the U1 snRNP, conferred by an absent
PRP(F)39-U1 snRNA interface, and in part by alternative
splicing of the prp(f)39 gene itself, which controls the level
of functional PRP(F)39.
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